Generated: September 23, 2017
DrugPatentWatch Database Preview
ACYCLOVIR Drug Profile
Which patents cover Acyclovir, and what generic Acyclovir alternatives are available?
is a drug marketed by Watson Labs, Amneal Pharms, Actavis Elizabeth, Apotex Inc, Glenmark Pharms Ltd, Mylan Pharms Inc, Zydus Pharms Usa Inc, Teva Pharms, Abbvie, Hi Tech Pharma, Mylan, Teva, Dava Pharms Inc, Fougera Pharms Inc, Chartwell Molecules, Hetero Labs Ltd V, Ivax Sub Teva Pharms, Tolmar, Actavis Mid Atlantic, Cadila Pharms Ltd, Lek Pharm, Carlsbad Technology, Taro, Roxane, Ranbaxy, Sun Pharm Inds Ltd, Carlsbad, Heritage Pharms Inc, Boscogen, Eurohlth Intl Sarl, Aurobindo Pharma Ltd, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Teva Parenteral, Hikma Pharms, Athenex Inc, and Apothecon. and is included in sixty NDAs.
The generic ingredient in ACYCLOVIR is acyclovir sodium. There are fifty-five drug master file entries for this compound. Seven suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the acyclovir sodium profile page.
Summary for Tradename: ACYCLOVIR
Pharmacology for Tradename: ACYCLOVIR
Mylan Labs Ltd
|INJECTABLE;INJECTION||203927-001||Mar 29, 2017||AP||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
Cadila Pharms Ltd
|TABLET;ORAL||202168-002||Nov 15, 2013||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|CAPSULE;ORAL||074750-001||Apr 22, 1997||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|INJECTABLE;INJECTION||074897-002||Feb 27, 1998||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|TABLET;ORAL||074976-001||Apr 13, 1998||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
Heritage Pharms Inc
|TABLET;ORAL||074891-001||Oct 31, 1997||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|TABLET;ORAL||074870-002||Jun 5, 1997||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|TABLET;ORAL||074976-002||Apr 13, 1998||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
Sun Pharm Inds Ltd
|TABLET;ORAL||074980-002||Sep 30, 1998||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
Heritage Pharms Inc
|TABLET;ORAL||074891-002||Oct 31, 1997||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.